ARGENX SE | NL0010832176 | Euronext exchange Live quotes

Caricamento in corso... Attendere.

Euronext Initiative dedicated to highlighting the visibility and attractiveness of high-growth and leading Tech companies towards international investors

Libro Ordini Centralizzato

Caricamento in corso... Attendere.

Performance storica

Caricamento in corso... Attendere.

Aggiornato16/04/2025 16:27 CEST

Regulated news

11/04/2025	argenx Announces Annual General Meeting of Shareholders on May 27, 2025
10/04/2025	argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generali...
08/04/2025	argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improve...
07/03/2025	argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at th...
27/02/2025	argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

Prezzo infragiornaliero

16/04/2025

Caricamento in corso... Attendere.

NOTICES

See All

10 Apr 2025	CE - Shares - Capital increase
22 Jan 2025	CE - Shares - Capital increase
12 Nov 2024	CE - Shares - Capital increase
16 Jul 2024	CE - Shares - Capital increase
10 Apr 2024	CE - Shares - Capital increase